Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.
Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...
In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...
A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...